Effects of Endotoxin in Normal Human Volunteers
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies, Hospital, Hospital, Pulmonary |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases, Other |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 5/24/2018 |
| Start Date: | April 6, 1992 |
| End Date: | May 17, 2018 |
The Cardiopulmonary Effects of Endotoxin in Normal Human Volunteers
Bacterial infections can progress to a life-threatening illness called septic shock,
characterized by low blood pressure and vital organ damage. The syndrome is thought to be
caused by parts of the bacteria and by the body s own immune response to the infection. A
major bacterial product that interacts with the immune defenses is called endotoxin. This
study will examine the body s response to endotoxin in the lungs or bloodstream. When
endotoxin is given in small amounts to humans, even though it is not an infection, it
triggers a set of responses that are typical of what one would see with a true bacterial
infection. This allows us to study the earliest changes in molecules and cells that are
involved in some bacterial infections. This type of model is safe and has been used in humans
for many years to understand the body s responses during infections.
Normal volunteers 18 to 45 years of age may be eligible for this study. Candidates will have
a history and physical examination, blood and urine tests, electrocardiogram (EKG) and chest
X-ray. In addition, volunteers 40 to 45 years old will have an exercise stress test to screen
for asymptomatic coronary artery disease. Participants will undergo one or more of the
following procedures:
Bronchoscopy, Bronchoalveolar Lavage, Bronchial Brushings, and Endobronchial Mucosal
Biopsies: These techniques for examining lung function are used routinely in patient care and
clinical research. The mouth and nasal and lung airways are numbed with an anesthetic. A
bronchoscope (pencil-thin flexible tube) is then passed through the nose into the large
airways of the lung. Cells and secretions from the airways are rinsed with salt water
(bronchoalveolar lavage) and a flexible brush the size of a pencil tip is passed through the
bronchoscope to scrape cells lining the airways. Lastly, pieces of tissue (the size of the
ball of a ballpoint pen) lining the airways are removed for examination under the microscope.
Intravenous Endotoxin: A small dose of endotoxin is injected into a vein. Blood samples are
drawn at regular intervals for 8 hours after the injection and again after 1, 2, 3, 7 and 14
days to analyze the body s immune response to the bacteria in the blood.
Instilled Endotoxin in the Lungs: A small amount (2 teaspoons) of salt water is squirted
through a bronchoscope into a lobe of one lung, and then salt water containing a small dose
of endotoxin is squirted into the other lung. Bronchial lavage, brushing, and biopsy (see
above) are then done to study the response of the lung to the endotoxin. In addition, air is
withdrawn through the bronchoscope to study air components from the lung that was instilled
with salt water or endotoxin.
Nitric Oxide Therapy: Endotoxin is instilled in a lung (see above) and then nitric oxide a
colorless, odorless, tasteless gas mixed with room air in a concentration of 40 parts per
million, is given through a cushioned mask placed over the mouth and nose. (Some participants
will be given the nitric oxide mixture and others will breathe only room air through the mask
to test the effects of the nitric oxide on the lung inflammation.) The mask will be worn
continuously for 6 hours and removed before repeat bronchoscopy with lavage, brushing and
biopsy.
Some of the above procedures require placement of a catheter (thin plastic tube) in a wrist
artery to monitor blood pressure from heartbeat to heartbeat and to collect blood samples.
First, the skin is numbed with an anesthetic (lidocaine). A needle is then inserted into the
artery, the catheter is slipped over the needle into the vessel, and the needle is removed.
characterized by low blood pressure and vital organ damage. The syndrome is thought to be
caused by parts of the bacteria and by the body s own immune response to the infection. A
major bacterial product that interacts with the immune defenses is called endotoxin. This
study will examine the body s response to endotoxin in the lungs or bloodstream. When
endotoxin is given in small amounts to humans, even though it is not an infection, it
triggers a set of responses that are typical of what one would see with a true bacterial
infection. This allows us to study the earliest changes in molecules and cells that are
involved in some bacterial infections. This type of model is safe and has been used in humans
for many years to understand the body s responses during infections.
Normal volunteers 18 to 45 years of age may be eligible for this study. Candidates will have
a history and physical examination, blood and urine tests, electrocardiogram (EKG) and chest
X-ray. In addition, volunteers 40 to 45 years old will have an exercise stress test to screen
for asymptomatic coronary artery disease. Participants will undergo one or more of the
following procedures:
Bronchoscopy, Bronchoalveolar Lavage, Bronchial Brushings, and Endobronchial Mucosal
Biopsies: These techniques for examining lung function are used routinely in patient care and
clinical research. The mouth and nasal and lung airways are numbed with an anesthetic. A
bronchoscope (pencil-thin flexible tube) is then passed through the nose into the large
airways of the lung. Cells and secretions from the airways are rinsed with salt water
(bronchoalveolar lavage) and a flexible brush the size of a pencil tip is passed through the
bronchoscope to scrape cells lining the airways. Lastly, pieces of tissue (the size of the
ball of a ballpoint pen) lining the airways are removed for examination under the microscope.
Intravenous Endotoxin: A small dose of endotoxin is injected into a vein. Blood samples are
drawn at regular intervals for 8 hours after the injection and again after 1, 2, 3, 7 and 14
days to analyze the body s immune response to the bacteria in the blood.
Instilled Endotoxin in the Lungs: A small amount (2 teaspoons) of salt water is squirted
through a bronchoscope into a lobe of one lung, and then salt water containing a small dose
of endotoxin is squirted into the other lung. Bronchial lavage, brushing, and biopsy (see
above) are then done to study the response of the lung to the endotoxin. In addition, air is
withdrawn through the bronchoscope to study air components from the lung that was instilled
with salt water or endotoxin.
Nitric Oxide Therapy: Endotoxin is instilled in a lung (see above) and then nitric oxide a
colorless, odorless, tasteless gas mixed with room air in a concentration of 40 parts per
million, is given through a cushioned mask placed over the mouth and nose. (Some participants
will be given the nitric oxide mixture and others will breathe only room air through the mask
to test the effects of the nitric oxide on the lung inflammation.) The mask will be worn
continuously for 6 hours and removed before repeat bronchoscopy with lavage, brushing and
biopsy.
Some of the above procedures require placement of a catheter (thin plastic tube) in a wrist
artery to monitor blood pressure from heartbeat to heartbeat and to collect blood samples.
First, the skin is numbed with an anesthetic (lidocaine). A needle is then inserted into the
artery, the catheter is slipped over the needle into the vessel, and the needle is removed.
Endotoxin is a unique molecule because it represents an important probe for investigating the
humoral and cellular basis of septic shock. Endotoxin administration to humans provides an
opportunity to evaluate the earliest responses that are activated after exposure to an
important bacterial component. Many alterations in organ function and circulating mediators
can be evaluated in this model. These changes are qualitatively similar to changes that occur
during sepsis and septic shock. The applications of new technologies to this model are useful
adjuncts to define mechanisms of acute inflammatory responses. Defining these pathways and
their interactions may allow a better understanding of the factors that can be controlled or
altered during critical illness.
In the current study, we are planning to extend previous observations on heart and lung
function after endotoxin administration in four separate studies.
1. Bronchoalveolar lavage and bronchial brushings in normal subjects. Bronchoalveolar
lavage and bronchial brushings will be performed in normal subjects to obtain alveolar
and epithelial pulmonary cells for use in vitro assays of respiratory cell function.
2. Inflammatory effects of systemic endotoxin administration. In order to evaluate late
inflammatory responses to IV endotoxin, blood will be obtained acutely and at 1, 2, 3,
7, and 14 days post endotoxin challenge.
3. Pulmonary effects of instilled endotoxin. Using bronchoscopy, the effects of direct
instillation of endotoxin into a lobe of the lung is being used to assess local
pulmonary inflammatory responses that result in neutrophil influx into the lung.
4. Effects of inhaled nitric oxide on pulmonary inflammatory responses following endotoxin
administration. In order to systematically study the effects of inhaled nitric oxide on
local lung inflammation, healthy subjects will undergo local endotoxin instillation,
breath NO through a mask for 6h, and then a repeat bronchoscopy will be done at 6h to
assess the ability of NO to suppress local inflammation in the lung.
humoral and cellular basis of septic shock. Endotoxin administration to humans provides an
opportunity to evaluate the earliest responses that are activated after exposure to an
important bacterial component. Many alterations in organ function and circulating mediators
can be evaluated in this model. These changes are qualitatively similar to changes that occur
during sepsis and septic shock. The applications of new technologies to this model are useful
adjuncts to define mechanisms of acute inflammatory responses. Defining these pathways and
their interactions may allow a better understanding of the factors that can be controlled or
altered during critical illness.
In the current study, we are planning to extend previous observations on heart and lung
function after endotoxin administration in four separate studies.
1. Bronchoalveolar lavage and bronchial brushings in normal subjects. Bronchoalveolar
lavage and bronchial brushings will be performed in normal subjects to obtain alveolar
and epithelial pulmonary cells for use in vitro assays of respiratory cell function.
2. Inflammatory effects of systemic endotoxin administration. In order to evaluate late
inflammatory responses to IV endotoxin, blood will be obtained acutely and at 1, 2, 3,
7, and 14 days post endotoxin challenge.
3. Pulmonary effects of instilled endotoxin. Using bronchoscopy, the effects of direct
instillation of endotoxin into a lobe of the lung is being used to assess local
pulmonary inflammatory responses that result in neutrophil influx into the lung.
4. Effects of inhaled nitric oxide on pulmonary inflammatory responses following endotoxin
administration. In order to systematically study the effects of inhaled nitric oxide on
local lung inflammation, healthy subjects will undergo local endotoxin instillation,
breath NO through a mask for 6h, and then a repeat bronchoscopy will be done at 6h to
assess the ability of NO to suppress local inflammation in the lung.
- INCLUSION CRITERIA:
1. 18 to 45 years of age, either male or female
2. Employees or non-employees are eligible
3. Normal screening examination:
1. history and physical examination, nonsmoker, no concurrent medications
including aspirin or nonsteroidal anti-inflammatory drugs, no active medical
problems;
2. complete blood count with differential and platelet counts;
3. serum chemistries including creatinine, blood urea nitrogen, glucose, liver
enzymes and function tests, electrolytes, prothrombin time, partial
thromboplastin time;
4. urinalysis;
5. female subjects must have negative urine pregnancy test within one week of
participation;
6. electrocardiogram;
7. chest radiograph.
4. If age is 40 to 45 years, normal submaximal stress test to screen for
asymptomatic coronary artery disease.
EXCLUSION CRITERIA:
Pregnancy.
Lactation.
History of recent clinically significant asthma.
Subjects who have an allergy to both sulfa- and penicillin-based drugs will not be eligible
for the endotoxin instillation portion of the study.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Click here to add this to my saved trials
